BIO
Camilla Ramdeen, Ph.D.
Executive Director, Strategic Feasibility
Dr. Camilla Ramdeen has led the global strategic feasibility team at Parexel since 2015 and has 16 years of CRO-based clinical research experience in feasibility and strategy, study start-up leadership, project management, investigator relationships and patient recruitment roles. Prior to joining the industry, she worked as an Oncology Dietitian and Academic Researcher at the Royal Marsden Hospital in London.